Medicine recalls
|
|
Recall 4 batches of Diprospan Injection (1ml ampoule) |
|
The Department of Health (DH) today (Jan 27) endorsed a licensed drug wholesaler Organon Hong Kong Limited (Organon), to recall 4 batches (batch number: U037539, W001030, W026080 & W032423) of Diprospan Injection (1ml ampoule) (Hong Kong Registration Number: HK-18689) from the market due to potential quality issue.
The DH received notification from Organon that the overseas manufacturer of the product is initiating a recall of the above batches due to detection of stainless steel particles in the product. As a precautionary measure, Organon is voluntarily recalling the affected batches from the market. DH investigation is continuing.
The above product, containing betamethasone dipropionate and betamethasone sodium phosphate, is a prescription medicine. Betamethasone is a steroid substance for treating inflammation. According to Organon, the affected batches of product have been imported into Hong Kong and supplied to the Hospital Authority, Department of Health clinics, private hospitals, private medical practitioners, pharmacies, and re-exported to Macau.
Organon has set up a hotline (3427 8171) to answer related enquiries. The DH will closely monitor the recall.
So far, the DH has not received any adverse reaction reports in connection with the above batches of product.
Ends/Friday, Jan 27, 2023
|
|
|